Phibro Animal Health (NASDAQ:PAHC) Issues Earnings Results, Beats Estimates By $0.14 EPS

Key Points

• Phibro Animal Health beat quarterly expectations: EPS was $0.85 versus the $0.71 consensus, while revenue reached $396.75 million, exceeding estimates of $381.18 million. The company updated its FY 2027 EPS guidance to $3.410–$3.590.
• Shares rose 0.4% to $36.09 following the results, although the stock remains well below its 52-week high of $60.08. Analysts maintain a consensus “Hold” rating with a $42.50 target price.
• The company declared a quarterly dividend of $0.12 per share, equivalent to $0.48 annually and a 1.3% yield; institutional investors own 99.34% of outstanding shares.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) released its quarterly earnings data on Wednesday. The company reported $0.85 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.14, FiscalAI reports. The business had revenue of $396.75 million for the quarter, compared to the consensus estimate of $381.18 million. Phibro Animal Health had a return on equity of 37.14% and a net margin of 6.35%. Phibro Animal Health updated its FY 2027 guidance to 3.410-3.590 EPS.

Phibro Animal Health Trading Up 0.4%

PAHC stock traded up $0.16 during trading on Wednesday, reaching $36.09. The company had a trading volume of 287,583 shares, compared to its average volume of 295,650. The company has a debt-to-equity ratio of 1.97, a current ratio of 3.17 and a quick ratio of 1.26. Phibro Animal Health has a 52 week low of $28.25 and a 52 week high of $60.08. The business has a 50 day moving average of $33.84 and a 200 day moving average of $42.54. The company has a market cap of $1.46 billion, a P/E ratio of 15.49, a PEG ratio of 0.50 and a beta of 0.46.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Wednesday, September 2nd will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, September 2nd. This represents a $0.48 annualized dividend and a dividend yield of 1.3%. Phibro Animal Health's payout ratio is currently 20.60%.

Wall Street Analysts Forecast Growth

PAHC has been the topic of several research analyst reports. Wall Street Zen lowered Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 9th. Citigroup lowered their price objective on shares of Phibro Animal Health from $62.00 to $44.00 and set a "neutral" rating on the stock in a research note on Thursday, May 14th. Zacks Research cut shares of Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research report on Thursday, May 21st. Finally, Weiss Ratings lowered shares of Phibro Animal Health from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Monday, June 15th. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $42.50.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. iSAM Funds UK Ltd bought a new stake in shares of Phibro Animal Health during the third quarter valued at approximately $61,000. C M Bidwell & Associates Ltd. raised its holdings in Phibro Animal Health by 1,756.5% in the fourth quarter. C M Bidwell & Associates Ltd. now owns 2,135 shares of the company's stock worth $80,000 after purchasing an additional 2,020 shares in the last quarter. Advisory Services Network LLC bought a new position in Phibro Animal Health in the third quarter worth $96,000. EverSource Wealth Advisors LLC lifted its position in Phibro Animal Health by 7,671.4% during the second quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company's stock valued at $69,000 after buying an additional 2,685 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in shares of Phibro Animal Health by 768.2% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,610 shares of the company's stock valued at $118,000 after buying an additional 4,079 shares in the last quarter. Institutional investors own 99.34% of the company's stock.

About Phibro Animal Health

Phibro Animal Health Corporation NASDAQ: PAHC is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro's portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source